• OPEN AN ACCOUNT
Indian Indices
Sensex
81,537.70 -769.67
( -0.94%)
Global Indices
Nasdaq
49,128.98 -276.04
(-0.56%)
Dow Jones
6,938.97 4.62
(0.07%)
Hang Seng
53,831.56 142.67
(0.27%)
Nikkei 225
10,138.52 -11.53
(-0.11%)
Forex
USD-INR
91.49 0.49
(0.54%)
EUR-INR
107.13 0.65
(0.61%)
GBP-INR
122.87 0.50
(0.41%)
JPY-INR
0.58 0.00
(0.49%)

EQUITY - MARKET SCREENER

Aditya Birla Sun Life Gold ETF
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
533408
INF209KB18D3
3.0089064
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BSLGOLDETF
0
2358.9
EPS(TTM)
Face Value()
Div & Yield %
0
0.1
0
 

Genomic Valley Biotech standalone net profit declines 93.75% in the December 2025 quarter
Jan 15,2026
Net profit of Genomic Valley Biotech declined 93.75% to Rs 0.01 crore in the quarter ended December 2025 as against Rs 0.16 crore during the previous quarter ended December 2024. Sales declined 77.27% to Rs 0.05 crore in the quarter ended December 2025 as against Rs 0.22 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales0.050.22 -77
OPM %20.0072.73 -
PBDT0.010.16 -94
PBT0.010.16 -94
NP0.010.16 -94